Sharekhan is bullish on Cipla and has recommended buy rating on the stock with a target price of Rs 795 in its research report dated November 6 , 2015.
Posts tagged MC
Sensex hits 26000 amid pressure; Tata Power, Havells gain (09-11-2015)
Tata Power gained 1.6 percent after better-than-expected earnings. Consolidated net profit stood at Rs 247.3 crore in September quarter against loss of Rs 77.75 crore in year-ago period on strong operational performance.
Hold Tata Steel;target of Rs 200:ICICI Direct (09-11-2015)
ICICI Direct has recommended hold rating on Ratnamani Tata Steel with a target price of Rs 200 in its research report dated November 6, 2015.
Hold Ratnamani Metals;target of Rs 670:Sharekhan (09-11-2015)
Sharekhan has recommended hold rating on Ratnamani Metals and Tubes with a target price of Rs 670 in its research report dated November 4, 2015.
Hold PTC India;target of Rs 68:ICICI Direct (09-11-2015)
ICICI Direct has recommended hold rating on PTC India with a target price of Rs 68 in its research report dated November 4, 2015.
Tata Power Q2 profit at Rs 247 cr on strong EBITDA, revenue (09-11-2015)
Revenue increased by 11 percent to Rs 9,541.2 crore in second quarter of FY16 compared to Rs 8,584 crore in same quarter last fiscal.
Sensex, Nifty continue to struggle; ITC, Tata Steel gain (09-11-2015)
Tata Motors, Maruti Suzuki, SBI, ITC and Tata Steel are top gainers in the Sensex. Among the losers are Sun Pharma, Dr Reddy’s Labs, BHEL, Wipro and ICICI Bank.
N Srinivasan sacked as ICC Chairman; BCCI prez to take over (09-11-2015)
The decision was taken during the BCCI’s 85th AGM meeting at its headquarters, here on Monday. Appointment of the ombudsman, or Ethics Officer, is one of the key changes that have been proposed in the BCCI’s Memorandum of Rules and Regulations to be taken up at the AGM.
Had largest ever real estate sale at Rs 1500 cr: Adi Godrej (09-11-2015)
Adi Godrej, Chairman at Godrej Industries, says all businesses did particularly well, especially Godrej Properties — its performance exceeded the entire previous year on topline
Sun Pharma tanks 7% on poor Q2, Halol woes: Wise to sell? (09-11-2015)
Credit Suisse downgraded the stock to neutral and slashed FY16/17/18 earnings per share (EPS) by 9/15/12 percent. It has also cut target multiple by 10 percent to Rs 775 per share.